1Mine Y. Yoshikawa T,Oku S,et al.Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro[].Journal of Pharmacology and Experimental Therapeutics.1997
2Yoshida N.Pharmacological effects of the gastoprokinetic agent mosapride citrate[].Nippon Yakurigaku Zasshi.1999
3Kanizumi T,Nakano H,Matsui T,et al.Effect of AS4370 on gastric emptying———double-blind clinical pharmacological study[].Nippon Heikatsukin Gakkai Zasshi.1990
4Yoshida N,Omoya H,Oka M,et al.AS-4370, a novel gastrokintic agent free of dopamine D2 receptor antagonist properties[].Archives Internationales de Pharmacodynamie.1989
5Carlsson L,Amos GJ,Andersson B.Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential[].Journal of Pharmacology and Experimental Therapeutics.1997
6Yoshida N,Omoya H,Kato S,et al.Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals[].ArzneimForsch/ Drug Res.1993
7Sakurai-Yamashita Y,Takada K,Takemura K,et al.Ability of mosapride to bind to 5-HT4 receptor in the human stomach[].Japanese Journal of Pharmacology.1999
8Yoshida N,Ito T,Karasawa T,et al.AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs[].Journal of Pharmacology and Experimental Therapeutics.1991
9Kii Y,Ito T.Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride on cardiac action potentials on guinea pig isolated papillary muscles[].Journal of Cardiovascular Pharmacology.1997
10Yoshida N,Omoya H,Furukawa K,et al.Pharmacological studies on mosapride citrate ( AS-4370 ), a gastroprokinetic agent(1): comparison with cisapride and metoclopramide[].Japanese Pharmacology and Therapeutics.1993
